Listing 1 - 10 of 82 | << page >> |
Sort by
|
Choose an application
This title details bioanalytical technologies and methods that have been developed using aptamers in analytical, medical, environmental, and food science applications.
Choose an application
OLIGONUCLEOTIDES --- POLYNUCLEOTIDES --- OLIGONUCLEOTIDES --- POLYNUCLEOTIDES
Choose an application
Oligonucleotides --- Oligonucleotides --- Oligonucleotides, --- Oligonucleotides --- Analysis --- Laboratory manuals. --- Synthesis --- Laboratory manuals. --- Chemistry.
Choose an application
Choose an application
Oligonucleotides --- Oligonucleotides. --- Oligonucleotides, Antisense. --- Anti-Sense Oligonucleotides --- Antisense Oligonucleotides --- Anti Sense Oligonucleotides --- Oligonucleotides, Anti-Sense --- Antisense Elements (Genetics). --- Nucleic Acids. --- Nucleotides --- Morpholinos --- Anti-Sense Oligonucleotide --- Antisense Oligonucleotide --- Anti Sense Oligonucleotide --- Oligonucleotide, Anti-Sense --- Oligonucleotide, Antisense --- Oligonucleotide --- Oligonucléotides
Choose an application
Oligonucleotides --- Electroporation --- Liposomes --- Skin Absorption
Choose an application
DNA --- Oligonucleotides. --- Organic electrochemistry. --- Synthesis.
Choose an application
Oligonucleotides --- Aptamers, Nucleotide. --- Aptamers, Peptide.
Choose an application
Drug delivery systems traditionally relied on passive diffusion mechanisms for targeting and releasing of therapeutically active molecules. The major problems associated with traditional delivery are poor specificity and dose-limited toxicity. Nanoparticles have found applicability in the development of novel drug delivery systems by easily overcoming toxicity problem. However, specificity of delivery has remained as a challenge. Developments in the methods of reaching to targeted tissue have lead to new and improved drug delivery platforms. Recently, active targeting has been incorporated by cell specific ligands such as antibodies, lectins, growth factor receptors. More recently, aptamers gained popularity in construction of novel actively targeted drug delivery systems (Ozalp et al., 2011). Considerable proportions of aptamer-based delivery systems have been incorporated to a variety of nanomaterials in order to improve their specific targeting properties (Chen et al., 2011; Zhou et al., 2011).
Oligonucleotides. --- Drug delivery systems. --- Nanoparticles.
Choose an application
Drug delivery systems traditionally relied on passive diffusion mechanisms for targeting and releasing of therapeutically active molecules. The major problems associated with traditional delivery are poor specificity and dose-limited toxicity. Nanoparticles have found applicability in the development of novel drug delivery systems by easily overcoming toxicity problem. However, specificity of delivery has remained as a challenge. Developments in the methods of reaching to targeted tissue have lead to new and improved drug delivery platforms. Recently, active targeting has been incorporated by cell specific ligands such as antibodies, lectins, growth factor receptors. More recently, aptamers gained popularity in construction of novel actively targeted drug delivery systems (Ozalp et al., 2011). Considerable proportions of aptamer-based delivery systems have been incorporated to a variety of nanomaterials in order to improve their specific targeting properties (Chen et al., 2011; Zhou et al., 2011).
Oligonucleotides. --- Drug delivery systems. --- Nanoparticles.
Listing 1 - 10 of 82 | << page >> |
Sort by
|